Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

363
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
363
Plant Breeding and Biotechnology01:59

Plant Breeding and Biotechnology

17.2K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
17.2K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

427
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
427
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

356
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
356
iChip01:24

iChip

93
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
93
Recombinant DNA01:09

Recombinant DNA

92.1K
Overview
92.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Online Voting: Should Ohio Adopt Online Voting for Voters with Disabilities?

Journal of law and health·2026
Same journal

Mental Illness, Probation, and Recidivism: Standardizing Uniform Mental Health Docket Legislation in Ohio.

Journal of law and health·2026
Same journal

Betting on the Body: Private Equity Portfolio Funding of Medical Malpractice Litigation and the Financialization of Patient Justice.

Journal of law and health·2026
Same journal

Roads to Regulation: A Discussion on Non-State Armed Groups' International Health Law Obligations.

Journal of law and health·2026
Same journal

FDA's New Approval Plan for COVID-19 Vaccines: An Inquiry of "Benefit" Rather than the Statutory Scope of "Safety, Purity, and Potency"?

Journal of law and health·2026
Same journal

Access to Healthcare for Irregular Migrants.

Journal of law and health·2026

Related Experiment Video

Updated: Apr 22, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

737

Patent Pending: How the Current Patent Utility Requirement Hinders Biotechnological Innovation.

    Journal of Law and Health
    |April 20, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Patent law struggles to keep pace with biotechnology innovation. Stricter utility requirements hinder patent protection for novel biotechnological inventions, impacting investment and scientific advancement.

    More Related Videos

    Isolation of Soil Microorganisms Using iChip Technology
    05:33

    Isolation of Soil Microorganisms Using iChip Technology

    Published on: January 10, 2025

    4.1K
    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
    09:08

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

    Published on: January 12, 2020

    6.3K

    Related Experiment Videos

    Last Updated: Apr 22, 2026

    Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
    06:34

    Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

    Published on: November 29, 2024

    737
    Isolation of Soil Microorganisms Using iChip Technology
    05:33

    Isolation of Soil Microorganisms Using iChip Technology

    Published on: January 10, 2025

    4.1K
    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
    09:08

    Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

    Published on: January 12, 2020

    6.3K

    Area of Science:

    • Biotechnology and Intellectual Property Law
    • Healthcare Innovation
    • Pharmaceutical Development

    Background:

    • Biotechnology drives innovation in human health and medicine, developing novel therapies and drugs.
    • Translating biotechnological discoveries into widespread use is a lengthy and costly process.
    • Investor funding is crucial for advancing biotechnological research from concept to application.

    Purpose of the Study:

    • To analyze the impact of current patent law on biotechnological innovation.
    • To highlight the discrepancy between the USPTO and Federal Circuit Court standards for biotechnological patents.
    • To advocate for a revised interpretation of the utility requirement to foster innovation.

    Main Methods:

    • Legal analysis of patent law, focusing on the utility requirement.
    • Examination of court decisions, particularly from the U.S. Court of Appeals for the Federal Circuit.
    • Comparative review of USPTO guidelines and judicial interpretations.

    Main Results:

    • The Federal Circuit's stringent utility standard limits patent protection for biotechnological innovations.
    • This restrictive interpretation deters investment in the biotechnology sector.
    • The U.S. Patent and Trademark Office has updated its criteria, but judicial application lags behind.

    Conclusions:

    • Revising the Federal Circuit's interpretation of the utility requirement is essential for patent law to support biotechnology.
    • Enhanced patent protection will encourage further investment and accelerate innovation in healthcare biotechnology.
    • Aligning legal standards with scientific advancements is critical for the progress of medicine and human health.